Congenital Pulmonary Airway Malformation Volume Ratio in Fetuses With Congenital Cystic Lung Diseases to Predict Surgery Within 7 Days of Birth Authors: Fumi Yanagisawa, Yuki Kamihara, Tomoyuki Shimokaze, Michi Kasai, Kyoko Mochizuki, Shigeru Aoki, Etsuko Miyagi, Hiromi Nagase, Hiroshi Ishikawa Published: 2026 ABSTRACT ABSTRACTAimTo identify congenital pulmonary airway malformation (CPAM) volume ratio (CVR) values that can predict the need for early neonatal surgery.MethodsWe retrospectively reviewed 70 infants diagnosed with congenital cystic lung diseases (CCLD) over the past 10 years at our center (10 with CPAM, 25 with intra‐ and extra‐lobar bronchopulmonary sequestrations, and 35 with bronchial atresia). Perinatal features, the maximum CVR during pregnancy, and the final CVR before delivery were compared between the early surgery group (surgery within 1 week of birth) and the follow‐up group (surgery after 1 week of birth or no surgery).ResultsAmong all fetuses with CCLD, the median maximum and final CVR values were 1.2 (interquartile range [IQR]: 0.7–1.9) and 0.5 (IQR: 0.2–0.9) with a median gestational age of 26 weeks (IQR: 24–30) and 34 weeks (IQR: 32–37), respectively. Early neonatal surgery was required in nine infants (five with CPAM, one with bronchopulmonary sequestrations, and three with bronchial atresia). Compared to the follow‐up groups, patients in the early surgery group had higher maximum CVR, higher final CVR, and a greater incidence of polyhydramnios. The maximum and final CVR thresholds of 1.86 and 0.9, yielded sensitivity of 78% and 78% and specificity of 80% and 85%, respectively. The areas under the curve for the maximum and final CVR values were 0.85 and 0.88, respectively.ConclusionA maximum CVR threshold of 1.86 and a final CVR threshold of 0.9 may be useful indicators for predicting the need for early neonatal surgery.Keywords: congenital lung diseases, newborn infant, operative surgical procedures, perinatal period, prenatal ultrasonography Introduction Congenital cystic lung diseases (CCLD) occur in 4–5 per 10 000 live births [1, 2]. They are classified into various clinical conditions such as congenital pulmonary airway malformation (CPAM), intra‐ and extra‐lobar bronchopulmonary sequestration (BPS), and bronchial atresia (BA) [1, 3, 4]. While most CCLD are asymptomatic after birth, approximately 14%–17% cause severe respiratory symptoms and require emergency surgery during the neonatal period [2, 5]. Previous studies evaluating neonatal surgery—typically defined as surgery performed within the first 28 or 30 days of life—have reported that the median age at operation in such cases is around five to six days [2, 6]. Given that symptomatic cases frequently necessitate surgery during the early neonatal period (within 7 days of birth), accurate prenatal prediction is essential to ensure adequate preparation and optimal surgical planning. Among the different histological subtypes, CPAM carries a higher risk of respiratory disorders than others [7, 8]. Reportedly, approximately 70% of infants with CCLD who need surgery during the neonatal period have CPAM [9]. However, the postnatal histopathological diagnosis often differs from the presumed prenatal classification [10]. Therefore, it is challenging to reliably predict whether early neonatal surgery is necessary from a prenatal diagnosis. Several prenatal ultrasound findings that predict neonatal respiratory compromise and surgery include ascites, hydrops, polyhydramnios, mediastinal shift, and congenital pulmonary airway malformation volume ratio (CVR) [11, 12, 13]. CVR is the height, length, and width ratio of the mass lesion from the ultrasound image, multiplied by a correction factor of 0.52 and divided by the fetal head circumference [14]. A CVR > 1.6 generally predicts a risk for hydrops fetalis and respiratory distress at birth [15]. Among various ultrasound findings, the CVR has been reported as the most reliable predictor of neonatal outcome [10, 11, 16]. Several studies have investigated the predictive value of the CVR for neonatal surgical intervention [6, 8, 9, 13, 16, 17]. The maximum CVR during pregnancy is often used [8, 13, 16]. However, there is no consensus on the optimal timing for its use. Penikis et al. reported that the optimal cutoff values predicting neonatal surgery were as follows: initial CVR ≥ 0.8, maximum CVR ≥ 1.5, and the final CVR ≥ 1.3. In their study, the final CVR was the best predictive for postnatal lung resection within 30 days [17]. In this study, we aimed to evaluate whether the maximum and final CVR values can predict the need for surgery in the early neonatal period (within the first week after birth) in infants prenatally diagnosed with CCLD. Methods This retrospective study was conducted at Kanagawa Children's Medical Center (a tertiary–care perinatal facility) in Japan. Among 73 patients born and postnatally diagnosed with CPAM, BPS, or BA, at our hospital between January 2013 and June 2023, 70 were included in this study. Three were excluded due to the presence of other structural anomalies– congenital diaphragmatic hernia, sacral caudal teratoma, and Alagille syndrome (which included pulmonary atresia with intact ventricular septum, major aortopulmonary collateral artery, and ileal atresia)–which affect respiration or timing of surgery. This study was approved by the Ethics Committee of our medical center (approval number 152–2). All pregnant women who delivered at our hospital underwent prenatal ultrasonography. According to Japanese guidelines, we conducted antenatal checkups every 4 weeks until 23 weeks of gestation, every 2 weeks from 24 to 35 weeks of gestation, and every week from 36 weeks of gestation to delivery. More frequent follow‐ups were conducted depending on the patient's condition [18]. Ultrasound examination was performed at each visit, and CVR was measured whenever possible. For each patient, CVR was measured by the same attending physician who was responsible for that case. The ultrasound equipment used included General Electric Voluson E8, E10, S10 (GE Healthcare, Chicago, IL, USA), or Aplio 400 (Canon, Tokyo, Japan). Histopathological examination results were used for definitive diagnosis in infants who underwent surgery. Imaging results from computed tomography and magnetic resonance imaging examinations were used in the final diagnosis of infants not requiring surgery. The maximum CVR during pregnancy (max CVR) and the CVR at the last ultrasound before delivery (final CVR) were selected for analysis. Management during the study period followed a consistent institutional policy. Early neonatal surgery was indicated when continuous oxygenation or positive pressure assistance was required, or when the lesion was enlarged. In asymptomatic cases, imaging evaluation was performed at 6 months of age, and resection surgery was planned at 1 year of age. In some cases, the lesion regressed spontaneously and became unresectable. However, in asymptomatic cases of extra‐lobar pulmonary sequestration (ELS), we usually choose conservative management. Detailed management strategies for ELS have been reported [19]. The patients were categorized into two groups: the early surgery group (surgery performed within 1 week after birth) and the follow‐up group (surgery performed after 1 week of birth or not required). The following variables were extracted from medical records: maternal age, parity, gestational age at first visit, delivery mode, birth weight, gestational age at birth (weeks), fetal sex, Apgar score, need for intubation, timing of surgery, neonatal death, prenatal diagnosis, postnatal diagnosis, fetal ultrasound findings (mass location, mass type, CVR, polyhydramnios, mediastinal shift, hydrops, structural abnormalities), thoraco‐amniotic shunting, and maternal corticosteroid treatment. Lesions with cysts > 5 mm were classified as macrocystic type, and those with cystic masses < 5 mm were classified as microcystic type [20]. Data are expressed as median and interquartile range (IQR). We compared baseline characteristics and perinatal outcomes between the two groups. The primary analysis evaluated whether the CVR can predict the need for early neonatal surgery. In secondary analyses, a cutoff value for the CVR that can predict the need for early neonatal surgery was calculated. When comparing the characteristics of patients between the two groups, the chi‐square test and Fisher's exact test were used to analyze the categorical variables, while the continuous variables were evaluated by applying the t‐test and Mann–Whitney U test. Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal cutoff values of the CVR for predicting surgery in the early neonatal period based on the Youden index [21]. All statistical analyses were performed using the statistical software package Stata SE 14 (STATA Corp, College Station, TX, USA), and a p value < 0.05 was considered statistically significant. Results Among the 70 patients with CCLD, 10 had CPAM, 25 had intra‐ and extra‐lobar BPS, and 35 had BA in the analysis. Of these 70 patients, 42 (60%) underwent surgery within the first year of life (nine of them required early neonatal surgery), and 10 patients underwent surgery after the first year of life. Diagnoses for the remaining 18 patients who have not had surgery to date were based on imaging results. The median gestational age at the first visit was 23 weeks of gestation (IQR: 21–26). All patients had at least one CVR measurement, and the median frequency of measurements was 6 (IQR: 3–9). The median max CVR was 1.20 (IQR: 0.72–1.89) with a median gestational age of 26 weeks (IQR: 24–30). The median final CVR value was 0.48 (IQR: 0.22–0.85). The median gestational age at the final CVR measurement was 34 weeks (IQR: 32–37). The median gestational age at delivery was 38.5 weeks (IQR: 38–40). There were five patients of preterm delivery (34–36 weeks of gestation). Comparison of characteristics and perinatal outcomes between the early surgery and follow‐up groups is shown in Tables 1 and 2. TABLE 1Comparison of characteristics between the early surgery and follow‐up groups.Early surgery (n = 9)Follow‐up (n = 61) p Maternal age (years)34 (28–36)31 (29–34)0.45Primipara6 (67)25 (41)0.171Gestational age at first visit (weeks)24 (23–27)23 (21–26)0.63Location of the malformationLeft6 (67)35 (57)0.73Right3 (33)25 (41)0.73Bilateral0 (0)1 (1)> 0.99Macrocystic type6 (67)39 (64)> 0.99Max CVR2.2 (1.9–2.5)1.0 (0.7–1.8)< 0.001Gestational age at the max CVR (weeks)34 (26–37)26 (24–29)< 0.001Final CVR1.89 (0.9–2.37)0.42 (0.21–0.73)< 0.001Gestational age at the final CVR (weeks)37 (34–38)34 (32–37)0.051Polyhydramnios5 (56)12 (20)0.033Mediastinal shift9 (100)47 (77)0.188Hydrops2 (22)0 (0)0.015Thoraco‐amniotic shunting2 (22)1 (2)0.042Maternal corticosteroid treatment2 (22)3 (5)0.120 Note: Data are presented as median (interquartile range) or Number (%).Abbreviations: CVR, congenital pulmonary airway malformation volume ratio; Max, maximum; n, number. Comparison of characteristics between the early surgery and follow‐up groups. Note: Data are presented as median (interquartile range) or Number (%). Abbreviations: CVR, congenital pulmonary airway malformation volume ratio; Max, maximum; n, number. TABLE 2Comparison of perinatal outcomes between the early surgery and follow‐up groups.Early surgery (n = 9)Follow‐up (n = 61) p Gestational age at birth (weeks)38 (37–38)39 (38–40)0.087Cesarean section3 (33)14 (23)0.68Birth weight (kg)3.08 (2.98–3.27)3.05 (2.72–3.32)0.31Sex (Male)4 (44)32 (53)0.73Five minute Apgar score < 70 (0)0 (0)> 0.99Postnatal diagnosisCPAM5 (56)5 (8)0.002BPS1 (11)24 (39)0.151BA3 (33)32 (53)0.48Need for intubation3 (33)1 (2)0.006Neonatal death1 (11)0 (0)0.129 Note: Data are presented as median (interquartile range) or Number (%).Abbreviations: BA, bronchial atresia; BPS, bronchopulmonary sequestration; CPAM, congenital pulmonary airway malformation; CVR, CPAM volume ratio; n, number. Comparison of perinatal outcomes between the early surgery and follow‐up groups. Note: Data are presented as median (interquartile range) or Number (%). Abbreviations: BA, bronchial atresia; BPS, bronchopulmonary sequestration; CPAM, congenital pulmonary airway malformation; CVR, CPAM volume ratio; n, number. A thoraco‐amniotic shunting was performed in three fetuses. However, in two of them, in the early surgery group, the shunt was displaced during pregnancy. The early surgery group had a greater max CVR, final CVR, and advanced gestational age at the time of the max CVR value. The early surgery group also had higher rates of polyhydramnios, hydrops, shunting, and tracheal intubation compared to the follow‐up group. ROC curves for the groups are shown in Figures 1 and 2. The ROC curves show the sensitivity and false positive rate for the max and final CVR values for predicting the need for early neonatal surgery. The areas under the curves for the max CVR and final CVR were 0.85 and 0.88, respectively. The cutoffs for the need for surgery within the first week of life were 1.86 (sensitivity 0.78, specificity 0.80, positive predictive value 0.37, and negative predictive value 0.96) and 0.90 (sensitivity 0.78, specificity 0.85, positive predictive value 0.44, and negative predictive value 0.96). The ROC curve analysis of max CVR for the prediction of the surgery during the early neonatal period (n = 70; early surgery group = 9, follow‐up group = 61). For a cut‐off value of 1.86, the specificity was 77.8% and the sensitivity was 80.3% with a positive predictive value of 36.8% and a negative predictive value of 96.1%. The area under the curve was 0.85 (95% CI, 0.74–0.97; p < 0.001; standard error 0.059). ROC, receiver operating characteristic; CI, confidence interval; CVR, congenital pulmonary airway malformations volume ratio. The ROC curve analysis of final CVR for the prediction of the surgery during the early neonatal period (n = 70; early surgery group = 9, follow‐up group = 61). For a cut‐off value of 0.9, the specificity was 77.8% and sensitivity was 85.2% with a positive predictive value of 43.8% and a negative predictive value of 96.3%. The area under the curve was 0.88 (95% CI, 0.74–1.00; p < 0.001; standard error 0.070). ROC, receiver operating characteristic; CI, confidence interval; CVR, congenital pulmonary airway malformations volume ratio. Details for the early surgery group are presented in Table 3. Hydrops fetalis was observed in two infants: Infant 1, the only infant deceased in this study, had skin edema and pleural effusion and died after emergency surgery at day 0. The pathological autopsy revealed pulmonary hypoplasia; and Infant 9 presented with skin edema and ascites; however, antenatal corticosteroid administration resulted in lesion reduction and improvement of hydrops. TABLE 3Details of the early surgery group.InfantAge at operation (d)Max CVR (GA)Final CVR (GA)HFCyst typeDiagnosisMode of deliveryGA at birth (w)Apgar score a IntubationDischarge (d)Outcome102.4 (34 w)2.4 (34 w)YesMacroCPAMCS358Yes—Death202.1 (34 w)1.9 (36 w)NoMacroCPAMVD378Yes35Alive302.5 (37 w)2.5 (37 w)NoMacroCPAMCS378No30Alive401.5 (31 w)1.4 (38 w)NoMacroCPAMCS389No19Alive523.5 (25 w)0.9 (33 w)NoMicroBAVD398No23Alive621.9 (24 w)0.4 (33 w)NoMacroBAVD389No14Alive742.2 (38 w)2.2 (38 w)NoMacroCPAMVD409No13Alive861.2 (37 w)0.6 (38 w)NoMicroELSVD388No15Alive964.3 (26 w)3.0 (37 w)YesMicroBAVD388Yes73AliveAbbreviations: BA, bronchial atresia; CPAM, congenital pulmonary airway malformation; CVR, CPAM volume ratio; CS, cesarean section; d, day; ELS, extra‐lobar pulmonary sequestration; GA, gestational age; HF, hydrops fetalis; m, month; max, maximum; VD, vaginal delivery; w, week; y, year. a Apgar score indicates the 5‐min Apgar score. Details of the early surgery group. Abbreviations: BA, bronchial atresia; CPAM, congenital pulmonary airway malformation; CVR, CPAM volume ratio; CS, cesarean section; d, day; ELS, extra‐lobar pulmonary sequestration; GA, gestational age; HF, hydrops fetalis; m, month; max, maximum; VD, vaginal delivery; w, week; y, year. Apgar score indicates the 5‐min Apgar score. In Cases 5 and 6, CVR values exhibited a decreasing trend in late gestation, and the lesions became difficult to visualize due to fetal position. Consequently, the last measurable CVR was obtained at 33 weeks of gestation, although both fetuses were delivered at 38–39 weeks. Infant 8 had both a max CVR and final CVR value lower than the cutoff values. After birth, the infant was diagnosed with ELS and did not require oxygenation but underwent surgery on day 6 due to a gradual enlargement and worsening mediastinal shift. Discussion In this study, we found that both max and final CVR values could predict the risk for surgery in patients with CCLD in the early neonatal period. Previous studies have examined whether the CVR can predict the need for postnatal surgery; however, the reported values for the max CVR that predicts the risk for surgery vary between studies [8, 13]. In contrast to the max CVR, the final CVR seems to be more consistent; values higher than 1.1 or 1.3 measured at 33 weeks of gestation have been reported to be predictors for postnatal surgery [9, 17]. In our study, max CVR > 1.86 and final CVR > 0.9 predicted the need for neonatal surgery within 7 days of life. These values differ from those reported previously, which suggested cutoff values of 1.5–1.6 and 1.1–1.3 for maximum and final CVR, respectively, as predictors of neonatal surgery within 28–30 days. The slightly higher maximum CVR and lower final CVR observed here may be explained by the somewhat later final CVR measurement timing in our cohort (overall median 34 weeks vs. 33 weeks in previous studies). Moreover, the relatively small sample size may have contributed to variability in the estimated cutoff values. Additionally, variation in histological subtype distribution may have influenced the thresholds. CVR values tend to decrease in the third trimester of pregnancy, partly because the fetal thoracic cavity grows more rapidly than the lung lesion [22]. In our early surgery group, max CVR was at 34 weeks because approximately half of the infants had macrocystic‐type CPAM, which continued to grow after 26 weeks of gestation. This increase was also due to the fact that both patients undergoing thoraco‐amniotic shunting dropped out. The final CVR measurement in the early surgery group tended to be at a later gestational age approximately 37 weeks, than in the follow‐up group. Given the known trend of decreasing CVR values in the third trimester of pregnancy, this later timing may have contributed to the lower final CVR cutoff observed in this study and should be considered when interpreting the findings. Our findings suggest that serial measurement of CVR until delivery may help better predict early surgery in cases with a CVR of approximately 0.9 or with an increasing trend even during the third trimester of pregnancy. Previous studies have reported the usefulness of the final CVR to predict neonatal surgery within 28 or 30 days after birth [9, 17]. Because most emergency surgeries in the neonatal period are performed within the first week of life, with multicenter data demonstrating a median age at operation of approximately 5–6 days [2, 6, 17], we focused on this clinically relevant timeframe. Moreover, as nearly half of our cases required surgery on the day of birth, we suggest that early prediction is essential for effective parental counseling and clinical preparedness (i.e., NICU preparation, coordination with pediatric surgeons, and perinatal management planning). Notably, one infant in the early surgery group, diagnosed with ELS, had both the max and final CVR values below the cutoff values. However, after birth, the mass increased and the mediastinal shift worsened, requiring surgery in the early neonatal period. Neonatal surgery is generally considered if a mass increases in size, and urgent surgery is required in cases of respiratory distress associated with massive pleural effusion [19]. This study had several strengths. We measured the CVR in cases with high CVR values until close to birth. To the best of our knowledge, this is the first study to focus on neonatal surgery within 7 days of life using the max and final CVR. However, the study also has some limitations. First, its retrospective design and the relatively small sample size limit the generalizability of our findings. Specifically, only nine neonates required surgery within 7 days, potentially limiting the stability and reliability of the ROC curve analysis. Therefore, larger prospective studies are needed to define optimal cutoff points. Second, there was a bias in the frequency of each disease in our study, with CPAM being the least prevalent. Although CPAM is the most common cystic lung disease, the pathologic classification of CCLD remains confusing, and a significant number of patients diagnosed with CPAM may actually have BA [7], suggesting that our cohort is not truly exceptional. Third, there was variation in the frequency of CVR measurements and the gestational age at the final CVR. The CVR measurement timing differed between groups, potentially affecting the comparison of final CVR values. The final CVR was obtained at a later gestational age in the early surgery group than in the follow‐up group; such a difference may have influenced the observed cutoff and statistical results. Moreover, a single attending physician measured the CVR of each patient, thereby minimizing intra‐observer variability within a case. Nevertheless, because multiple physicians were involved in the study, interobserver variability could not be completely eliminated. In conclusion, a maximum CVR threshold of 1.86 and a final CVR threshold of 0.9 may be useful indicators for predicting the need for early neonatal surgery. Nonetheless, caution is warranted because of the limited sample size and single‐center design. Larger multicenter studies should validate these findings to establish optimal management strategies for congenital cystic lung disease. Author Contributions Michi Kasai: methodology, validation, formal analysis, writing – review and editing. Kyoko Mochizuki: methodology, validation, formal analysis, writing – review and editing. Fumi Yanagisawa: conceptualization, investigation, writing – original draft. Hiroshi Ishikawa: writing – review and editing, supervision, project administration. Hiromi Nagase: writing – review and editing, resources, data curation. Yuki Kamihara: conceptualization, methodology, validation, formal analysis, writing – original draft, writing – review and editing, visualization. Shigeru Aoki: writing – review and editing. Tomoyuki Shimokaze: methodology, validation, formal analysis, writing – original draft, writing – review and editing. Etsuko Miyagi: writing – review and editing. Funding This study was supported by a clinical research grant from the Kanagawa Children's Medical Center. Disclosure Dr. Shigeru Aoki is an Editorial Board member of the Journal of Obstetrics and Gynecology Research and a co‐author of this article. To avoid any potential conflict of interest, Dr. Aoki was completely excluded from the editorial and peer review process for this manuscript. Ethics Statement This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was obtained from the Institutional Review Board for Clinical Research of Kanagawa Children's Medical Center (approval number: 152‐2). Consent Since this was a retrospective study using de‐identified data from medical records, written informed consent was not required. In accordance with the approval of the Ethics Committee, information about the study was disclosed on the hospital website to provide patients with the opportunity to opt out. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments We would like to thank Editage (www.editage.jp) for the English language editing. Yanagisawa F., Kamihara Y., Shimokaze T., et al., “Congenital Pulmonary Airway Malformation Volume Ratio in Fetuses With Congenital Cystic Lung Diseases to Predict Surgery Within 7 Days of Birth,” Journal of Obstetrics and Gynaecology Research 52, no. 5 (2026): e70327, 10.1111/jog.70327. An earlier version of this study was presented at the 60th Annual Meeting of the Japan Society of Perinatal and Neonatal Medicine, held in Osaka, Japan, in July 2024. Data Availability Statement The data that support the findings of this study are derived from medical records and fetal ultrasound data collected at Kanagawa Children's Medical Center. Although the data were de‐identified before analysis, they originate from sensitive clinical information and therefore cannot be made publicly available due to privacy and ethical restrictions imposed by the Institutional Review Board. De‐identified aggregate data may be available from the corresponding author upon reasonable request and with permission from the Ethics Committee of Kanagawa Children's Medical Center. References Associated Data Data Availability Statement The data that support the findings of this study are derived from medical records and fetal ultrasound data collected at Kanagawa Children's Medical Center. Although the data were de‐identified before analysis, they originate from sensitive clinical information and therefore cannot be made publicly available due to privacy and ethical restrictions imposed by the Institutional Review Board. De‐identified aggregate data may be available from the corresponding author upon reasonable request and with permission from the Ethics Committee of Kanagawa Children's Medical Center.